Jan 10, 2024: We start 2024 with two new profiles – from Austria and Montenegro!
Austria and Montenegro – We now have databases from these two countries for the first time in our resource:
Austria and Montenegro – We now have databases from these two countries for the first time in our resource:
Institute for Medicines and Medical Devices of Montenegro
Boulevard Ivana Crnojevića 64a
Podgorica 81000
MONTENEGRO
Email: info@cinmed.me
You may also complete the Contact Form at: https://cinmed.me/en/contact/
22nd ISoP Annual Meeting “Putting Patients First in Pharmacovigilance: International Perspectives from Global South” 6–9 November 2023 Bali, Indonesia. Drug Saf 46, 1173–1295 (2023). https://doi.org/10.1007/s40264-023-01350-z
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy. Drug Saf 45, 1111–1327 (2022). https://doi.org/10.1007/s40264-022-01219-7
20th ISoP Annual Meeting “Integrated pharmacovigilance for safer patients” 8–10 November 2021 Muscat, Oman (Hybrid meeting). Drug Saf 44, 1391–1470 (2021). https://doi.org/10.1007/s40264-021-01129-0
NOTE: Abstracts for the ISoP Annual Meetings are published as a part of the Drug Safety journal
EB House Austria
Sophie Kitzmueller
Muellner Haupstraße 48
AUSTRIA
Email: s.kitzmueller@salk.at
EB House Austria
Martin Laimer
Muellner Haupstraße 48
AUSTRIA
Email: m.laimer@salk.at
N/A
Researchers, Mentors and PhD students, consider subscribing to B.R.I.D.G.E. TO DATA®* and find the perfect database for your study or project! B.R.I.D.G.E. TO DATA® is a unique online reference profiling population healthcare databases for use in epidemiology and health outcomes research.
The Nurses' Health Studies, comprising 4 cohorts - NHS, NHS2, NHS3 and GUTS (Growing Up Today Study), are among the largest prospective investigations into the risk factors for major chronic diseases in women and more recently, men. Starting with the original Nurses’ Health Study in 1976, the studies are now in their third generation with Nurses’ Health Study 3 (still enrolling male and female nurses) and count >275,000 participants. Forty-seven years since the beginning, over 200,000 participants continue to contribute data, biospecimens, and participate in ancillary studies.
For individuals seeking general information about the Studies -
Email: nhs@channing.harvard.edu
Telephone: +1 617-525-2279
Address:
Nurses Health Study/Harvard Cohorts and Biorepository
Channing Division of Network Medicine
Brigham and Women's Hospital
181 Longwood Avenue
Boston, MA 02115
USA
For researchers interested in collaboration, please see https://nurseshealthstudy.org/researchers
Dr. Heather Eliassen
Email: heliasse@hsph.harvard.edu
Dr. Jorge Chavarro
Email: jchavarr@hsph.harvard.edu
Dr. Jaime Hart
Email: jhart@hsph.harvard.edu
Dr. Walter Willett
Email: wwillett@hsph.harvard.edu
1. Ha J, Mehta RS, Cao Y, Huang T, Staller K, Chan AT. Assessment of Gastroesophageal Reflux Symptoms and Sleep Quality Among Women in the Nurses' Health Study II. JAMA Netw Open. 2023 Jul 3;6(7):e2324240.
2. Chen Z, Khandpur N, Desjardins C, Wang L, Monteiro CA, Rossato SL, Fung TT, Manson JE, Willett WC, Rimm EB, Hu FB, Sun Q, Drouin-Chartier JP. Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies. Diabetes Care. 2023 Jul 1;46(7):1335-1344.
3. Denckla CA, Hahn J, Cowden RG, Ho S, Gao K, Espinosa Dice AL, Jha SC, Kang JH, Shear MK. Bereavement, Memorial Attendance, and Mental Health During the COVID-19 Pandemic: Longitudinal Results from the Nurses' Health Study. Am J Geriatr Psychiatry. 2023 Jun 28:S1064-7481(23)00345-7.
4. Yang K, Tabung FK, Whitehead WE, Giovannucci EL, Chan AT, Staller K. Proinflammatory Diet Is Associated With Increased Risk of Fecal Incontinence Among Older Women: Prospective Results From the Nurses' Health Study. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1657-1659.e3.
5. Shafrir AL, Mu F, Eliassen AH, Thombre Kulkarni M, Terry KL, Hankinson SE, Missmer SA. Endogenous Steroid Hormone Concentrations and Risk of Endometriosis in Nurses' Health Study II. Am J Epidemiol. 2023 Apr 6;192(4):573-586.
6. Bozigar M, Huang T, Redline S, Hart JE, Grady ST, Nguyen DD, James P, Nicholas B, Levy JI, Laden F, Peters JL. Associations between Aircraft Noise Exposure and Self-Reported Sleep Duration and Quality in the United States-Based Prospective Nurses' Health Study Cohort. Environ Health Perspect. 2023 Apr;131(4):47010.
7. Cui J, Malspeis S, Choi MY, Lu B, Sparks JA, Yoshida K, Costenbader KH. Risk prediction models for incident systemic lupus erythematosus among women in the Nurses' health study cohorts using genetics, family history, and lifestyle and environmental factors. Semin Arthritis Rheum. 2023 Feb;58:152143.
8. Shan Z, Wang F, Li Y, Baden MY, Bhupathiraju SN, Wang DD, Sun Q, Rexrode KM, Rimm EB, Qi L, Tabung FK, Giovannucci EL, Willett WC, Manson JE, Qi Q, Hu FB. Healthy Eating Patterns and Risk of Total and Cause-Specific Mortality. JAMA Intern Med. 2023 Feb 1;183(2):142-153.
9. Li H, Hart JE, Mahalingaiah S, Nethery RC, James P, Bertone-Johnson E, Eliassen AH, Laden F. Environmental Exposures and Anti-Müllerian Hormone: A Mixture Analysis in the Nurses' Health Study II. Epidemiology. 2023 Jan 1;34(1):150-161.
10. Peng C, Zeleznik OA, Shutta KH, Rosner BA, Kraft P, Clish CB, Stampfer MJ, Willett WC, Tamimi RM, Eliassen AH. A Metabolomics Analysis of Circulating Carotenoids and Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):85-96.
Do you know anyone who may qualify for the Judith K. Jones Award for Impact on Public Health through Pharmacoepidemiology? See this link and nominate them by January 31, 2024. (NOTE: You do have to be a member of the International Society for Pharmacoepidemiology to nominate, but the nominee does not have to be one.
- The Swedish Rheumatology Quality Register (SRQ) is a national quality register with the aim of continuously improving the treatment and follow-up of patients with rheumatic diseases. SRQ was started in 1996, mainly for patients with RA, but over time it has been expanded to cover several other rheumatic diseases including ankylosing spondylitis (AS) and psoriatic arthritis (PsA), myositis, systemic lupus erythematosus (SLE) and additional conditions.